Table of Content


Introduction
B-Cell Chronic Lymphocytic Leukemia - Overview
B-Cell Chronic Lymphocytic Leukemia - Therapeutics Development
B-Cell Chronic Lymphocytic Leukemia - Therapeutics Assessment
B-Cell Chronic Lymphocytic Leukemia - Companies Involved in Therapeutics Development
B-Cell Chronic Lymphocytic Leukemia - Drug Profiles
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects
B-Cell Chronic Lymphocytic Leukemia - Discontinued Products
B-Cell Chronic Lymphocytic Leukemia - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for B-Cell Chronic Lymphocytic Leukemia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for B-Cell Chronic Lymphocytic Leukemia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by AB Science SA, H2 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by Alexion Pharmaceuticals Inc, H2 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by AstraZeneca Plc, H2 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BeiGene Ltd, H2 2020
B-Cell Chronic Lymphocytic Leukemia - Pipeline by BioIntegrator Ltd, H2 2020
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, H2 2020
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, H2 2020 (Contd..1), H2 2020
B-Cell Chronic Lymphocytic Leukemia - Dormant Projects, H2 2020 (Contd..2), H2 2020
B-Cell Chronic Lymphocytic Leukemia - Discontinued Products, H2 2020